• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Information and Computing Technologies for the 21st Century (ICT21) Data Center Migration (1)

Description: Provide an Agency-wide, 21st-century computing infrastructure that is secure, scalable, flexible, and reliable to meet FDA’s business missions.

Accomplishment: The Office of Information Management and Technology (OIMT) successfully completed the data center modernization and migration project which provided an advanced computing infrastructure that is secure, scalable, flexible and reliable and able to meet the agency's mission. As a result of this initiative, the FDA now has a Tier 4 production data center environment with a secure FDA computing environment. A Tier 4 data center is considered the most robust type of data center and is inherently less prone to failures. FDA has formalized the development, test, pre-production/user acceptance testing and production environments. This provides an internal cloud computing environment which reduces FDA’s costs for environment setup and support, and provides agility not previously possible. Additionally, FDA has established consistency and standardization through new operational procedures and processes. Key outcomes achieved which enhance FDA operational efficiency and cost savings include an 89.1% server reduction through virtualization and a reduction in the number of Agency applications from 397 to 265. Virtualization allows FDA to run multiple systems on a single high-performance server instead of each system requiring a separate server. Through virtualization, FDA has reduced the physical server footprint which demonstrates savings in power consumption costs from a server and data center standpoint and allows FDA to utilize equipment and support resources more efficiently. Approximately 110 database servers were consolidated into 18 servers, for an 84% reduction of physical equipment. The overall data center infrastructure reliability has increased from 98.3% to 99.9996% meaning that unscheduled server downtime has been reduced from 6.6 days per calendar year to approximately 30 seconds. A high-performance computing enclave has also been established to support the FDA's bioinformatics initiatives. FDA's new data centers already meet or exceed all 2012 and 2013 Executive Order and HHS green computing and consolidation goals.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Authority to Operate (ATO) for the White Oak Data Center


Completed 4/30/2010

B. First production application live in modern data center


Completed 6/1/2010

C. All OIM managed applications live in modern data center





Completed 3/20/2011

D. All OIM managed applications (except Virtual Memory System [VMS] based) moved out of the old data center


Completed 3/31/2011


  • (1) The dates in italics under the milestone due dates are revised milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised due dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.